Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
2022 · Blood · 2,785 citations
https://doi.org/10.1182/blood.2022016867
J
Jianxiang Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
838
Papers
18.4K
Citations
57
h-index
227
i10-index
Jianxiang Wang is an academic researcher from Dongbei University of Finance and Economics. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research. The author has an h-index of 57, co-authored 713 publications.
ORCID: 0000-0001-9437-9151Papers by this author
worksAzacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
2020 · New England Journal of Medicine · 2,662 citations
https://doi.org/10.1056/nejmoa2012971
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
2019 · Journal of Hematology & Oncology · 184 citations
https://doi.org/10.1186/s13045-019-0732-7
Long‐term follow‐up of <scp>VIALE‐A</scp>: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia
2024 · American Journal of Hematology · 177 citations
https://doi.org/10.1002/ajh.27246
Precision therapy for acute myeloid leukemia
2018 · Journal of Hematology & Oncology · 150 citations
https://doi.org/10.1186/s13045-017-0543-7
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
2020 · Journal of Hematology & Oncology · 107 citations
https://doi.org/10.1186/s13045-020-00953-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat